|
Variable
|
Frequency % N(300)
|
Median (Q1–Q3)
|
Mean ± SD
|
Mean rank
|
P value
|
|---|
|
Age category (years)
|
< 0.001 b
|
|
< 30
|
31 (10.3)
|
15.00(14.00–15.00)
|
14.55 ± 0.89
|
255.40
|
|
30–60
|
163 (54.3)
|
12.00(11.00–14.00)
|
12.08 ± 1.97
|
159.84
|
|
> 60
|
106 (35.3)
|
11.00(9.00–12.00)
|
10.69 ± 1.93
|
105.45
|
|
Gender
|
0.015 a
|
|
Male
|
115 (38.3)
|
12.00(10.00–12.00)
|
11.47 ± 1.98
|
133.34
|
|
Female
|
185 (61.7)
|
12.00(11.00–14.00)
|
12.07 ± 2.26
|
159.92
|
|
BMIa
|
0.003b
|
|
Normal
|
65 (21.7)
|
12.00(11.00–15.00)
|
12.63 ± 2.08
|
178.75
|
|
Overweight
|
136 (45.3)
|
12.00(10.00–13.00)
|
11.57 ± 2.30
|
139.13
|
|
Obese
|
93 (31.0)
|
12.00(10.00–13.00)
|
11.58 ± 1.94
|
137.90
|
|
Education
|
< 0.001 b
|
|
Illiterate
|
20 (6.7)
|
9.50(9.00–11.00)
|
10.05 ± 1.57
|
75.45
|
|
Elementary
|
43 (14.3)
|
11.00(9.00–12.00)
|
10.76 ± 1.76
|
101.92
|
|
Primary
|
52 (17.3)
|
12.00(10.00–13.00)
|
11.73 ± 2.15
|
145.35
|
|
Secondary
|
54 (18.0)
|
12.00(11.00–14.00)
|
12.19 ± 2.13
|
159.62
|
|
University
|
124 (41.3)
|
12.00(11.00–15.00)
|
12.38 ± 2.15
|
166.65
|
|
Income (month)
|
0.641 b
|
|
Less than 2000 NIS
|
23 (7.7)
|
12.00(11.00–15.00)
|
12.17 ± 2.61
|
160.98
|
|
2000–5000 NIS
|
160(53.3)
|
12.00(11.00–14.00)
|
11.82 ± 2.20
|
145.83
|
|
More than 5000 NIS
|
108(36.0)
|
12.00(10.00–13.00)
|
11.75 ± 2.09
|
143.06
|
|
locality
|
0.258 b
|
|
Camp
|
36 (12.0)
|
12.00(11.00–14.75)
|
12.25 ± 2.08
|
161.86
|
|
Rural
|
85(28.3)
|
12.00(11.00–15.00)
|
12.02 ± 2.30
|
153.71
|
|
Urban
|
172(57.3)
|
12.00(10.00–13.00)
|
11.66 ± 2.14
|
140.58
|
|
Marital status
|
0.003 b
|
|
Married
|
229(76.3)
|
12.00(11.00–14.00)
|
12.01 ± 2.14
|
127.51
|
|
Unmarried (single, divorced, widowed)
|
67(22.3)
|
11.00(10.00–13.00)
|
11.37 ± 2.14
|
154.64
|
|
Employment status
|
0.188 a
|
|
Employed
|
194(64.7)
|
12.00(10.00–13.25)
|
12.10 ± 1.80
|
156.46
|
|
Unemployed
|
100(33.3)
|
12.00(11.00–14.00)
|
11.73 ± 2.32
|
142.88
|
|
Chronic co-morbid disease
|
0.018b
|
|
No co-morbid disease
|
42 (14.0)
|
14.00(12.00–15.00)
|
12.14 ± 1.96
|
216.07
|
|
One disease
|
44(14.7)
|
12.00(10.00–14.00)
|
11.99 ± 2.10
|
152.50
|
|
Two diseases
|
63(21.0)
|
12.00(10.00–14.00)
|
12.05 ± 2.06
|
154.00
|
|
Three diseases or more
|
146(48.7)
|
11.00(10.00–12.00)
|
11.20 ± 2.05
|
123.50
|
|
Indications for anticoagulant
|
< 0.001 b
|
|
Atrial fibrillation
|
63 (21.0)
|
11.00 (9.00–12.00)
|
10.84 ± 1.90
|
112.70
| |
|
Deep vein thrombosis or Pulmonary embolism
|
29 (9.7)
|
12.00 (10.50–15.00)
|
12.31 ± 2.58
|
167.93
| |
|
Prophylaxis c
|
72 (24.0)
|
13.00 (12.00–15.00)
|
13.11 ± 1.87
|
203.99
|
|
Other indications
|
136 (45.3)
|
11.00 (10.00–12.75)
|
11.53 ± 2.03
|
135.98
|
|
Chronic medications
|
< 0.001 a
|
|
≤4
|
176(58.7)
|
12.00(11.00–15.00)
|
12.25 ± 2.23
|
167.30
|
|
> 4
|
124(41.3)
|
11.00(10.00–12.00)
|
11.26 ± 1.96
|
126.65
|
|
Anticoagulant drug
|
< 0.001 a
|
|
UHF
|
87(29)
|
11.00(10.00–12.00)
|
11.04 ± 1.74
|
113.63
|
|
Vit-K dependent
|
134(44.7)
|
11.50(10.00–13.00)
|
11.52 ± 2.22
|
135.54
|
|
NOACs
|
75(25)
|
13.00(12.00–15.00)
|
13.07 ± 1.89
|
198.53
|
- a The statistical significance of the differences was calculated using the Mann-Whitney U test
- b The statistical significance of the differences was calculated using the Kruskal-Wallis test
- Bold P-value indicates significant differences.c Patients that received prophylactic doses of unfractionated heparin during hospital admission
- NIS: New Israeli Shekel (0.29 US Dollar)
